PEC vs Excelsior Biopharma: monthly revenue

Monthly revenue and year-on-year change for PEC (6446) and Excelsior Biopharma (6496) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ PEC ━ Excelsior Biopharma

0%+108%-16%25/1026/0126/0426/0726/10

Monthly revenue history

MonthPECYoYExcelsior BiopharmaYoY
Oct 2026NT$2.84 billion+102.0%NT$94.8 million+32.6%
Sep 2026NT$2.64 billion+100.0%NT$76.4 million+7.3%
Aug 2026NT$2.62 billion+105.4%NT$65.8 million-4.0%
Jul 2026NT$2.51 billion+92.6%NT$88 million+30.4%
Jun 2026NT$2.33 billion+94.9%NT$69.4 million+10.1%
May 2026NT$2.46 billion+108.5%NT$77.8 million+6.9%
Apr 2026NT$2.06 billion+68.3%NT$85.3 million+28.9%
Mar 2026NT$1.94 billion+64.4%NT$66 million-16.2%
Feb 2026NT$1.6 billion+56.7%NT$56.4 million-6.6%
Jan 2026NT$1.58 billion+49.8%NT$95.6 million+35.1%
Dec 2025NT$1.92 billion+69.9%NT$125.6 million+34.2%
Nov 2025NT$1.55 billion+53.0%NT$82.1 million+12.3%
Oct 2025NT$1.4 billion+53.6%NT$71.5 million-3.4%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16